Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review
- PMID: 26908513
- PMCID: PMC4769413
- DOI: 10.1136/bmjopen-2015-009070
Incidence of adult Huntington's disease in the UK: a UK-based primary care study and a systematic review
Abstract
Objectives: The prevalence of Huntington's disease (HD) recorded in the UK primary care records has increased twofold between 1990 and 2010. This investigation was undertaken to assess whether this might be due to an increased incidence. We have also undertaken a systematic review of published estimates of the incidence of HD.
Setting: Incident patients with a new diagnosis of HD were identified from the primary care records of the Clinical Practice Research Datalink (CPRD). The systematic review included all published estimates of the incidence of HD in defined populations.
Participants: A total of 393 incident cases of HD were identified from the CPRD database between 1990 and 2010 from a total population of 9,282,126 persons.
Primary and secondary outcome measures: The incidence of HD per million person-years was estimated. From the systematic review, the extent of heterogeneity of published estimates of the incidence of HD was examined using the I(2) statistic.
Results: The data showed that the incidence of HD has remained constant between 1990 and 2010 with an overall rate of 7.2 (95% CI 6.5 to 7.9) per million person-years. The systematic review identified 14 independent estimates of incidence with substantial heterogeneity and consistently lower rates reported in studies from East Asia compared with those from Australia, North America and some--though not all--those from Europe. Differences in incidence estimates did not appear to be explained solely by differences in case ascertainment or diagnostic methods.
Conclusions: The rise in the prevalence of diagnosed HD in the UK, between 1990 and 2010, cannot be attributed to an increase in incidence. Globally, estimates of the incidence of HD show evidence of substantial heterogeneity with consistently lower rates in East Asia and parts of Europe. Modifiers may play an important role in determining the vulnerability of different populations to expansions of the HD allele.
Keywords: EPIDEMIOLOGY; GENETICS.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Similar articles
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280. Health Technol Assess. 2001. PMID: 11701100
-
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240. Health Technol Assess. 2006. PMID: 16796930
-
Electronic cigarettes for smoking cessation.Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 Nov 17;11:CD010216. doi: 10.1002/14651858.CD010216.pub7. PMID: 34519354 Free PMC article. Updated.
Cited by
-
Pooling of primary care electronic health record (EHR) data on Huntington's disease (HD) and cancer: establishing comparability of two large UK databases.BMJ Open. 2024 Feb 14;14(2):e070258. doi: 10.1136/bmjopen-2022-070258. BMJ Open. 2024. PMID: 38355188 Free PMC article.
-
The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records.BMC Med. 2022 Feb 2;20(1):43. doi: 10.1186/s12916-022-02247-x. BMC Med. 2022. PMID: 35105363 Free PMC article.
-
Natural history and burden of Huntington's disease in the UK: A population-based cohort study.Eur J Neurol. 2022 Aug;29(8):2249-2257. doi: 10.1111/ene.15385. Epub 2022 May 27. Eur J Neurol. 2022. PMID: 35514071 Free PMC article.
-
Antagonistic pleiotropy in mice carrying a CAG repeat expansion in the range causing Huntington's disease.Sci Rep. 2019 Jan 10;9(1):37. doi: 10.1038/s41598-018-37102-8. Sci Rep. 2019. PMID: 30631090 Free PMC article.
-
Unraveling Molecular Targets for Neurodegenerative Diseases Through Caenorhabditis elegans Models.Int J Mol Sci. 2025 Mar 26;26(7):3030. doi: 10.3390/ijms26073030. Int J Mol Sci. 2025. PMID: 40243699 Free PMC article. Review.
References
-
- Novak MJ, Tabrizi SJ. Huntington's disease. BMJ 2010;341:34–40. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical